Abstract
ABSTRACTIntroduction:The rapid spread of coronavirus disease 2019 (COVID-19) has dramatic effects on individuals and health care systems. In our institute, a tertiary oncologic public hospital with high surgical volume, we prioritize maintaining cancer treatment as well as possible. The aim of this study is to evaluate if uro-oncological surgeries at pandemic are safe.Materials and Methods:We evaluated patients who underwent uro-oncological procedures. Epidemiological data, information on COVID-19 infection related to surgery and clinical characteristics of non-survival operative patients with COVID-19 infections were analyzed.Results:From 213 patients analyzed, Covid-19 symptoms were noticed in 8 patients at preoperative process or at hospital admission postponing operation; 161 patients were submitted to elective surgery and 44 to emergency surgery. From patients submitted to elective surgeries, we had 1 patient with laboratory confirmation of COVID-19 (0,6%), with mild symptoms and quick discharge. From the urgencies group, we had 6(13%) patients tested positive; 5 were taken to ICU with 4 deaths.Conclusion:Elective uro-oncological procedures at the COVID-19 epidemic period in a COVID-19-free Institute are safe, and patients who need urgent procedures, with a long period of hospitalization, need special care to avoid COVID-19 infection and its outcomes.
Highlights
The rapid spread of coronavirus disease 2019 (COVID-19) has dramatic effects on individuals and health care systems
The rapid spread of coronavirus disease 2019 (COVID-19), caused by a novel betacoronavirus known as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), throughout the World, has dramatic effects on individuals and health care systems far beyond those infected with SARS-CoV-2 [1]
Of the 205 operated,17 patients presented signs or symptoms suggestive of COVID-19 infection at some point after the procedure, 7 of which had the diagnosis confirmed by quantitative RT-PCR on samples from the respiratory tract
Summary
The rapid spread of coronavirus disease 2019 (COVID-19) has dramatic effects on individuals and health care systems. Conclusion: Elective uro-oncological procedures at the COVID-19 epidemic period in a COVID-19-free Institute are safe, and patients who need urgent procedures, with a long period of hospitalization, need special care to avoid COVID-19 infection and its outcomes. The rapid spread of coronavirus disease 2019 (COVID-19), caused by a novel betacoronavirus known as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), throughout the World, has dramatic effects on individuals and health care systems far beyond those infected with SARS-CoV-2 [1]. Owing to more advanced age, the impossibility of receiving adequate medical care, and the fact that cancer patients have 3.5 folds risk of developing COVID-19 related serious events, all elective surgeries, chemotherapy, and radiotherapy procedures in stable patients should be deferred [4,5,6]. The decision of postponing cancer surgeries or not will depend on patient condition/decision and hospital capacity in providing intensive care units, ventilators and transfusion support among other resources needed for major cancer surgeries [7]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
